4-Methylmorpholine → HCID 86646545, compound
Reaction equation
[F:1][C:2]1[CH:10]=[CH:9][C:8]([CH2:11][C:12]2[CH:17]=[C:16]([C:18]([F:24])([F:23])[C:19]([F:22])([F:21])[F:20])[C:15](=[O:25])[NH:14][N:13]=2)=[CH:7][C:3]=1[C:4]([OH:6])=O.[F:26][C:27]([F:32])([F:31])[C:28]([O-:30])=[O:29].[CH:33]1([N:38]2[CH2:43][CH2:42][NH2+:41][CH2:40][C:39]2=[O:44])[CH2:37][CH2:36][CH2:35][CH2:34]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CN1CCOCC1>CN(C=O)C.C(Cl)Cl>[F:26][C:27]([F:32])([F:31])[C:28]([O-:30])=[O:29].[CH:33]1([N:38]2[CH2:43][CH2:42][N:41]([C:4]([C:3]3[CH:7]=[C:8]([CH:9]=[CH:10][C:2]=3[F:1])[CH2:11][C:12]3[CH:17]=[C:16]([C:18]([F:24])([F:23])[C:19]([F:22])([F:21])[F:20])[C:15](=[O:25])[NH:14][NH+:13]=3)=[O:6])[CH2:40][C:39]2=[O:44])[CH2:37][CH2:36][CH2:35][CH2:34]1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
OO7, 4-cyclopentyl-3-oxopiperazin-1-ium trifluoroacetate (1 eq.), TBTU (1 eq.) and N-methyl-morpholine (2.2 eq.) were stirred for 2 h in DMF. The product was purified by preparative HPLC (water/MeCN, 0.1% TFA as eluents) and desired pooled product fractions were lyophilized to afford a white powder. The powder was dissolved in DCM and washed with sat. aq. NaHCO3. The organic phase was dried (Na2SO4), filtered and concentrated to dryness to afford the product as colourless oil. 1H-NMR (300 MHz, DMSO-d6) δ: 13.52 (1H, s), 7.90 (1H, s), 7.46-7.22 (3H, m), 4.82-4.65 (1H, m), 4.15 (1H, s), 4.03 (2H, s), 3.80 (2H, s), 3.42-3.20 (3H, m), 1.80-1.40 (8H, m). MS (ES) C23H22F6N4O3 requires: 516, found: 517 (M+H)+.
Workup
- customThe product was purified by preparative HPLC (water/MeCN, 0.1% TFA as eluents)
- customto afford a white powder
- washwashed with sat. aq. NaHCO3
- dry with materialThe organic phase was dried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated to dryness
Sources & evidence
- ORD record
- ord-a4965a971ebf42b4867ff04fe4cc7101
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08268827B2
Reaction notes
Loading…